Insider Transactions in Q2 2024 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-39.25%
|
$520,000
$52.04 P/Share
|
|
Jun 28
2024
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.18%
|
$220,000
$22.5 P/Share
|
|
Jun 27
2024
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-39.25%
|
$510,000
$51.93 P/Share
|
|
Jun 27
2024
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.18%
|
$220,000
$22.5 P/Share
|
|
Jun 26
2024
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-39.25%
|
$510,000
$51.82 P/Share
|
|
Jun 26
2024
|
Nicole La Brosse SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.18%
|
$220,000
$22.5 P/Share
|
|
Jun 18
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-5.61%
|
$490,000
$49.43 P/Share
|
|
Jun 18
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.31%
|
$80,000
$8.11 P/Share
|
|
Jun 12
2024
|
Matthew L. Posard |
SELL
Open market or private sale
|
Direct |
10,000
-9.11%
|
$500,000
$50.62 P/Share
|
|
Jun 11
2024
|
Matthew L. Posard |
SELL
Open market or private sale
|
Direct |
10,000
-8.35%
|
$500,000
$50.01 P/Share
|
|
May 22
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-5.61%
|
$450,000
$45.38 P/Share
|
|
May 22
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.31%
|
$80,000
$8.11 P/Share
|
|
May 21
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-5.61%
|
$450,000
$45.16 P/Share
|
|
May 21
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.31%
|
$80,000
$8.11 P/Share
|
|
Apr 25
2024
|
Matthew L. Posard |
BUY
Grant, award, or other acquisition
|
Direct |
6,501
+5.15%
|
-
|
|
Apr 25
2024
|
Connie Matsui |
BUY
Grant, award, or other acquisition
|
Direct |
6,501
+3.25%
|
-
|
|
Apr 25
2024
|
Akiko Moni Miyashita |
BUY
Grant, award, or other acquisition
|
Direct |
6,501
+23.84%
|
-
|
|
Apr 25
2024
|
Mahesh Krishnan |
BUY
Grant, award, or other acquisition
|
Direct |
6,501
+50.0%
|
-
|
|
Apr 25
2024
|
Jeffrey William Henderson |
BUY
Grant, award, or other acquisition
|
Direct |
6,501
+10.81%
|
-
|
|
Apr 25
2024
|
Bernadette Connaughton |
BUY
Grant, award, or other acquisition
|
Direct |
6,501
+12.2%
|
-
|
|
Apr 25
2024
|
Barbara Gayle Duncan |
BUY
Grant, award, or other acquisition
|
Direct |
6,501
+29.21%
|
-
|
|
Apr 17
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-5.61%
|
$380,000
$38.49 P/Share
|
|
Apr 17
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.31%
|
$80,000
$8.11 P/Share
|
|
Apr 16
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-5.61%
|
$380,000
$38.35 P/Share
|
|
Apr 16
2024
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.31%
|
$80,000
$8.11 P/Share
|